CureApp, a company engaged in the research and development of "therapeutic apps®," prescribed by physicians, has successfully raised approximately 2.1 billion yen in funding, bringing their total funding amount to 6.4 billion yen
The Japanese trading company is the first corporate shareholder to join leAD, the leading global sports and health tech ecosystem
